Back to Orbis Allan Gray Ltd

ALNY
8 quarters

Position history for Orbis Allan Gray Ltd's holdings in ALNYLAM PHARMACEUTICALS INC

Orbis Allan Gray Ltd holds 1.3M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $441.7M as of 2026-Q1. The position was decreased (-17.5% shares). ALNY represents 1.9% of Orbis Allan Gray Ltd's portfolio.

Current Value

$441.7M

Current Shares

1.3M

Total Value Change

+$266.4M

Total Shares Change

+613,772

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.3M
-17.5%
$441.7M1.9%$318.65
0
2025-Q4
Decreased
1.6M
-17.1%
$643.5M2.7%$397.25
0
2025-Q3
Decreased
2M
-8.0%
$889.6M3.8%$447.49
0
2025-Q2
Increased
2.1M
+29.8%
$691.8M3.4%$322.83
73
2025-Q1
Increased
1.6M
+11.0%
$441.5M2.5%$268.46
59
2024-Q4
Increased
1.5M
+16.1%
$346.6M1.9%$236.01
57
2024-Q3
Increased
1.3M
+75.9%
$348.8M1.8%$274.91
74
2024-Q2
New
721,053
-
$175.2M1.1%$243.00
70

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used